New drug BBT002 aims to ease sinusitis and asthma in early trial
Disease control
Not yet recruiting
This early-stage study tests a new drug called BBT002 in healthy volunteers and people with chronic sinusitis, nasal polyps, and asthma. The main goal is to check safety and how the body handles the drug. Up to 64 participants will receive either BBT002 or a placebo to see if it …
Phase: PHASE1, PHASE2 • Sponsor: Bambusa Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:42 UTC